Сравнение на методи
Прегледайте избраните методи един до друг; редовете с разлики са откроени.
| Анализ на преживяемостта× | Съгласуване по показател на склонност× | |
|---|---|---|
| Област | Статистика за изследвания | Статистика за изследвания |
| Семейство | Process / pipeline | Process / pipeline |
| Година на възникване≠ | 1958 | 1983 |
| Създател≠ | Edward L. Kaplan and Paul Meier | Paul Rosenbaum and Donald Rubin |
| Тип | Method | Method |
| Основополагащ източник≠ | Kaplan, E. L., & Meier, P. (1958). Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53(282), 457–481. DOI ↗ | Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70(1), 41–55. DOI ↗ |
| Други названия | Kaplan-Meier analysis, Cox regression, TTE analysis | PSM, propensity score weighting, covariate balance |
| Свързани | 3 | 3 |
| Резюме≠ | Survival analysis is a collection of statistical methods for modeling time from a defined starting point until an event of interest occurs (disease, recovery, death, equipment failure). Kaplan and Meier's nonparametric estimator (1958) and David Cox's proportional hazards model (1972) jointly enabled analysis of censored data—individuals whose event times are unknown because they left the study or were still event-free at follow-up. Indispensable in oncology, cardiology, infectious disease research, engineering reliability, and any field where time-to-event matters. | Propensity score matching (PSM) is a method for reducing confounding bias in observational studies by balancing baseline characteristics between treatment groups, simulating randomization. Developed by Rosenbaum and Rubin (1983), it estimates the probability of receiving treatment given observed covariates, then matches or weights treated and control individuals with similar treatment probabilities. Widely used in medicine, epidemiology, and policy evaluation when randomized trials are infeasible or unethical, enabling estimation of treatment effects while controlling for selection bias. |
| ScholarGateНабор от данни ↗ |
|
|